RyvuTx@RyvuTx

Ryvu Therapeutics is developing novel small molecule therapies that address clinical limitations of current treatments in oncology.

 Krakow, Poland
ryvu.com/
Joined June 2019
469 Photos and videos
On November 5, Krzysztof Brzozka, Chief Scientific Officer at Ryvu, will speak at the #ADC Payload Summit 2026 in Boston. Join Krzysztof's session and connect with us to discuss the future of ADC payload innovation.
1
101
Ryvu presented new preclinical proof-of-concept data for RVU602, our proprietary, potentially first-in-class ADC payload with a mechanism of action distinct from both TOPO1 and tubulin inhibitors. 🔗 Read more: lnkd.in/dU5N4v6P
4
133
Today, Agnieszka Ludwig-Słomczyńska will present new preclinical in vivo proof-of-concept data for RVU602 at World ADC 2026 in San Diego! Join her!
3
96
On September 29, Krzysztof Brzozka, CSO at Ryvu, will speak at the Drug Discovery Innovation Programme Europe 2026 in Basel. If you are attending DDIP Europe, join the session and meet Krzysztof in Basel.
2
151
Aleksandra Sabiniarz, Director of Research Operations will represent Ryvu at the 25th Scientific Congress of the Polish Pharmaceutical Society in Wrocław, September 22-25. Ola will speak during the first plenary session. Learn more: ptfarmzjazd.pl/
2
177
Ryvu has signed a grant agreement with the National Centre for Research and Development. The agreement provides up to PLN 105.6 million in funding for the project “PANACEA-NOVO - patient-oriented innovative targeted therapies for rare cancers” lnkd.in/dr2v5YNj
8
252
Ryvu Therapeutics has reported its financial results for H1 2026 and provided an update on recent clinical and corporate progress. Read the H1 2026 report: lnkd.in/eh7jb6QU and the press release: lnkd.in/e4V8zD4H
2
126
On September 9-10, Karolina Osowska will attend the Oncology & Immunology Innovation Partnering & Licensing Summit. If you would like to discuss Ryvu’s oncology pipeline and partnering opportunities, connect with Karolina through the event’s one-to-one partnering portal.
2
131
Today, we are launching Keelira, our dedicated early clinical development services business for biotech and pharma companies seeking to extend oncology programs into Europe. Read the press release: ryvu.com/press-release/ryvu-… Learn more about Keelira: keelira.com
1
129
The MEDWAY project is moving forward, and we are proud to be part of it! The Children’s Memorial Health Institute officially launched a new investigator-initiated, non-commercial Phase I clinical study. More: ryvu.com/press-release/rvu12…
1
1
150
Thank you to Minister Pełczyńska-Nałęcz, Secretary of State Szyszko, and everyone from the Ministry of Development Funds and Regional Policy who joined us for an open and substantive conversation. We look forward to continuing this dialogue!
Katarzyna Pełczyńska
@Kpelczynska
Jul 30
Po raz pierwszy w historii powstaje lek wynaleziony i w całości opracowany przez naszych naukowców i naszą rodzimą firmę. Tak warto budować rozwój. Wsparte z KPO i Funduszy 🇪🇺🇵🇱
3
258
Po raz pierwszy w historii powstaje lek wynaleziony i w całości opracowany przez naszych naukowców i naszą rodzimą firmę. Tak warto budować rozwój. Wsparte z KPO i Funduszy 🇪🇺🇵🇱
32
48
352
12,102
Ryvu Therapeutics and MENARINI Group have amended their global license agreement for #dapolsertib (MEN1703/SEL24). Read more: lnkd.in/gVSaaDiv
4
368
We're headed to the BIO International Convention, June 22-25, in San Diego, CA! This year, you can find the Ryvu Therapeutics team: Vatnak Vat-Ho and Kamil Sitarz, PhD, MBA, at the PAIH – Polish Investment & Trade Agency booth #1411. #BIO2026 #Partnering #RyvuTx
4
309
Już 12 czerwca o godz. 16:10 prof. Bozenna Dembowska-Bagińska przedstawi założenia projektu #MEDWAY podczas XIII Zjazdu PTOiHD w Gdańsku. Ryvu jest częścią tej inicjatywy! O konferencji: lnkd.in/drbHHSr4 O projekcie MEDWAY: ryvu.com/pl/komunikat-prasow…
1
218
EHA 2026 is now underway, and our posters are available online. Read more: lnkd.in/dGsdd5xj View the posters: lnkd.in/dnmFMG8d #RyvuTx #Romaciclib #EHA2026 #AML #Myelofibrosis #ClinicalResearch #Hematology
1
227
The countdown is almost over! #EHA2026 starts tomorrow, and we can't wait to be back together with the hematology community in Stockholm!
3
189
Berlin, June 16. Two sessions. One mission: better #ADCs for patients. Ryvu's CSO Krzysztof Brzozka takes the stage at Discovery & Development Europe 2026 (Estrel Congress Centre, 15–16 June) with a packed afternoon. Join him!
3
147
We're heading to #EHA2026, and we'd love to see you there! Come meet us at our booth A2.05, explore our latest science, and join us for two important poster presentations featuring romaciclib (RVU120).
5
206
This week, conversations around Ryvu’s science will take place not only in Kraków, but also in Chicago during #ASCO2026. From May 29 – June 2, 2026, Vatnak Vat-Ho will represent Ryvu Therapeutics at this event.
1
6
429
Load more